Showing ultrasensitive capabilities similar to most RT-QuIC assays, AD RT-QuIC can amplify at least fM quantities of tau seeds, making it also comparable in sensitivity to the cell-based assays for tau seeding activity [30]. The gene discussed is MAPT; the disease is Alzheimer disease.